NCT00654342

Brief Summary

The technique of sentinel lymph node mapping in patients with colon cancer varies among reports, and the optimal method remain to be established. The purpose of this study was to determine the optimal injection technique for sentinel lymph node mapping for colon cancer.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 2, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 8, 2008

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2009

Completed
Last Updated

April 8, 2008

Status Verified

April 1, 2008

Enrollment Period

1.3 years

First QC Date

April 2, 2008

Last Update Submit

April 2, 2008

Conditions

Keywords

Sentinel lymph node-colon cancer

Outcome Measures

Primary Outcomes (1)

  • Accuracy & sensitivity of sentinel lymph node mapping

    After confirmed pathological report

Study Arms (2)

1

OTHER

In vivo injection group

Procedure: Intraoperative injection (in vivo)

2

OTHER

Ex vivo injection group

Procedure: Postoperative injection (ex vivo)

Interventions

Intraoperative injection

1

postoperative injection

2

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stage I - III colon cancer patients

You may not qualify if:

  • cancer located at the low rectum which were located within 10 cm of the dentate, recurrent or metastatic colon carcinoma, adjacent organ invasion tumor, prior chemotherapy or radiation, cancer with intestinal obstruction, past intestinal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, Chung-Ang university Hospital

Seoul, 156-755, South Korea

RECRUITING

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Postoperative Period

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Perioperative PeriodSurgical Procedures, OperativePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Central Study Contacts

In-Taik Chang, M.D., Ph.D.

CONTACT

Jun Seok Park, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 2, 2008

First Posted

April 8, 2008

Study Start

October 1, 2007

Primary Completion

February 1, 2009

Last Updated

April 8, 2008

Record last verified: 2008-04

Locations